Ticagrelor Use in Indian Patients Undergoing Neuroendovascular Procedures: A Single Center Experience

Neurointervention
Vivek KaranVikram Huded

Abstract

A safe and efficacious antiplatelet drug is needed for patients with clopidogrel resistance who undergo neuroendovascular procedures. Ticagrelor is a new reversibly binding, oral, direct-acting P2Y receptor antagonist with no known resistance. We describe our clinical experience using ticagrelor for neuroendovascular procedures in Indian patients with clopidogrel resistance at the NH Institute of Neurosciences, Narayana Health City, Bangalore. We retrospectively reviewed our endovascular procedure database for all patients with predefined clopidogrel resistance. Clopidogrel resistance was defined as P2Y12 inhibition <40%. Patients were administered ticagrelor along with aspirin prior to the procedure. Of 127 patients, 32 (25%) were non-responders to clopidogrel (22 [69%] males, 10 [31%] females; median age, 54 years [range, 20-75]). All patients were treated with a 180-mg loading dose of ticagrelor, followed by 90 mg twice daily. Twenty patients (63%) underwent endovascular intervention for intracranial aneurysm, two (6%) for dissecting aneurysms, nine (28%) for stenotic lesions, and one (3%) for carotico-cavernous fistula. No patient experienced any adverse effects related to the use of Ticagrelor in the postoperative period. ...Continue Reading

References

Oct 19, 2006·Expert Opinion on Drug Safety·Glen E Cooke, Pascal J Goldschmidt-Clermont
Apr 10, 2007·Journal of the American College of Cardiology·Dominick J AngiolilloMarco A Costa
Nov 9, 2007·AJNR. American Journal of Neuroradiology·S PrabhakaranD K Lopes
Dec 23, 2008·Journal of Thrombosis and Thrombolysis·Tobias HeerUNKNOWN Acute Coronary Syndromes (ACOS) Registry Investigators
Aug 8, 2009·The American Journal of Cardiology·Tina L Pinto SlottowRon Waksman
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Sep 15, 2009·Journal of Advanced Nursing·Robyn Gallagher, Sharon McKinley
Jan 19, 2010·Lancet·Christopher P CannonUNKNOWN PLATelet inhibition and patient Outcomes Investigators
Feb 9, 2010·Expert Review of Cardiovascular Therapy·Davide CapodannoDominick J Angiolillo
Sep 11, 2010·Journal of the American College of Cardiology·Laurent BonelloUNKNOWN Working Group on High On-Treatment Platelet Reactivity
Jun 17, 2011·Thrombosis Research·Tomoaki HigoKazuhisa Kodama
Oct 13, 2011·Journal of Neurointerventional Surgery·Doniel DrazinMichael J Alexander
Jan 1, 2010·Journal of Blood Medicine·Kade BirkelandRobert Rosenstein
Jan 1, 2013·AJNR. American Journal of Neuroradiology·C GohB Yan
Jun 19, 2013·Journal of Neurointerventional Surgery·Ricardo A HanelWilliam D Freeman
Jun 25, 2013·Journal of Neurointerventional Surgery·Grant C SorkinAdnan H Siddiqui

❮ Previous
Next ❯

Citations

Apr 21, 2021·Journal of the Neurological Sciences·A HonigJ E Cohen
Jun 25, 2021·Vascular Health and Risk Management·Rahul ChandraKonark Malhotra

❮ Previous
Next ❯

Software Mentioned

pCONUS
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.